Riskpilot← Back to searchSign inGet full accessBiomedical Bonding AB
ABActiveOrg 5567545735Teknikringen 38 AAll other professional, scientific and technical activities n.e.c. · NACE 7499Est. 20081-4 employees
Revenue 2024
SEK 0
EBITDA margin
—
+71% vs 2023
Equity ratio
88.4%
Financial strength
Net profit 2024
SEK -1,2M
+69% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -1M | +71% |
| Net profit | SEK -1,2M | +69% |
| Total assets | SEK 6,3M | +43% |
| Equity | SEK 5,5M | +349% |
| Employees | — | — |
Legal name
Biomedical Bonding AB
Org number
5567545735
Legal form
Aktiebolag
NACE code
7499 · All other professional, scientific and technical activities n.e.c.
Founded
29 mars 2008
Share capital
SEK 201 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska utveckla material och metoder i syfte att effektivisera klinisk behandling av benskador och för andra medicinska tillämpningar samt därmed förenlig verksamhet.
Address
Teknikringen 38 A
Phone
+46812156755
Email
michael.malkoch@biomedicalbonding.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 0 | 66 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −172 | −77 | −81 | −197 | −82 | 941 | −1 539 | −2 844 | −3 568 | −1 029 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −71 | −92 | −161 | −177 |
| EBIT | −172 | −77 | −81 | −197 | −82 | 941 | −1 610 | −2 936 | −3 729 | −1 206 |
| Net financials | −1 | — | — | — | — | — | — | −4 | 21 | 44 |
| Profit before tax | −173 | −77 | −81 | −197 | −82 | 941 | −1 610 | −2 939 | −3 709 | −1 162 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −173 | −77 | −81 | −197 | −82 | 941 | −1 610 | −2 939 | −3 709 | −1 162 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 38 | 13 | 58 | 166 | 499 | 4 121 | 4 660 | 7 229 | 4 386 | 6 269 |
| Equity | −5 | −44 | 43 | 119 | 157 | 3 555 | 4 282 | 5 958 | 1 235 | 5 541 |
| Long-term debt | 0 | 0 | 0 | 0 | 263 | 263 | 263 | 188 | 188 | 188 |
| Short-term debt | 43 | 57 | 15 | 46 | 80 | 303 | 115 | 1 084 | 2 963 | 541 |
| Total debt | 43 | 57 | 15 | 46 | 343 | 566 | 378 | 1 272 | 3 151 | 729 |
EBITDA margin
-102900000.0%
This company
15.8%
Market median
-651265923% vs market
20152024
Equity ratio
88.4%
This company
38.2%
Market median
+131% vs market
20152024
Return on equity
-21.0%
This company
18.4%
Market median
-214% vs market
20152024
Net profit margin
-116200000.0%
This company
8.1%
Market median
-1434568001% vs market
20152024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152024
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
EM Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
MM Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
JE | Audit | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2024 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Biomedical Bonding AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Evelina Maria Mikaelson | Chief Executive Officer | 0 companies |
| Michael Malkoch | Chief Executive Officer | 0 companies |
| Johan Erik Niclas Bergenmo | Audit | 0 companies |
| Lena Carina Söderström | Board of Directors | 0 companies |
| Anna Elvira Carlmark Malkoch | Deputy Board Member | 0 companies |
| Viktor Johan Henrik Granskog | Board of Directors | 0 companies |
| Charlotte Eva Catrin Molund | Board of Directors | 0 companies |
| Daniel Malkoch | Board of Directors | 0 companies |
| Rami Elias | Board of Directors | 0 companies |